Abstract
This paper presents insights from the Psychedelic Therapists Diversity (PTD) study, a qualitative study conducted to understand how BIPOC therapists perceive psychedelic therapy and research. The inciting incident for this research occurred during our collaboration on a clinical trial of psilocybin-assisted therapy for depression in cancer patients.1 Candace Oglesby was the only therapist of color, and the participant population included only a small number of patients of color. Recognizing she was not the only therapist who experienced challenges and barriers to entering the psychedelic therapy space, she realized that studying this experience would fill a significant research gap and could potentially support BIPOC clinicians.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call